Sino Medical Sciences Technology Inc. (SHA: 688108), a prominent player in the medical device industry in China, has announced that its HT Supreme drug-eluting stent system has received marketing approval in Mexico. This development marks a significant expansion of the company’s global footprint.
The HT Supreme system is a state-of-the-art drug-device combination product, comprising a drug-coated expandable cobalt chromium (CoCr) alloy coronary artery stent and an accompanying balloon delivery system. The stent’s design features a non-corrosive polymer layer at its base, overlaid with a biodegradable polymer layer that facilitates drug release. The drug-eluting component, which includes a blend of sirolimus and biodegradable polymers, is delivered via a rapid exchange balloon expandable system, ensuring efficient stent deployment.
The HT Supreme stent system is now approved for use in Mexico to enhance the coronary artery lumen diameter in patients with symptomatic heart disease resulting from primary coronary artery lesions up to 40 millimeters in length, with reference vessel diameters ranging from 2.25 to 5.00 millimeters. This product has already gained registrations in the European Union, China, Thailand, Singapore, Indonesia, and other regions, highlighting its broad acceptance and utility in treating cardiovascular conditions.- Flcube.com
